Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the ...

The device demonstrates a MARD of 8% and includes a 12-hour grace period and mobile app compatibility.

Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be ...

Influencers have found their latest wellness obsession — and, once again, diabetics got there first. First, came GLP-1 drugs.

Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...

Ahead of the premiere of Camp Rock 3, we caught up with Nick Jonas about returning to Camp Rock as a producer, working with ...

The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...

Apple, Samsung, Google, Garmin, and Huawei smartwatches can flag health risks beyond glucose, including hypertension, sleep ...

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large ...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...

FDA's crackdown on online ketamine retailers, unprecedented health care premium hikes, and more health news from Morning ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...